AstraZeneca plunges on promoter stake sale plans
By IRIS
06th March 2013 10:18 AM
AstraZeneca Pharma India, an integrated
biopharmaceutical companyplunged on Wednesday after the
multinational pharmaceutical company said that its promoter
AstraZeneca Pharmaceuticals AB Sweden has decided to reduce its
shareholding in the company to meet minimum public shareholding
norm. The current shareholding of the promoter in the company is
approximately 89.99%.
Shares ofthe companyare trading at Rs
769.95, down Rs 63.8, or 7.65% at the Bombay Stock Exchange (BSE)
on Wednesday at 9:39 a.m.The scrip has touched an intra-day high of
Rs 798.45 and low of Rs 711.20. The total volume of shares traded
at the BSE is 39,661.In the earlier session, the shares fell 3.38%,
or Rs 29.15, at Rs 833.75. Currently, the stock is trading at all
time 52-week low, which is below 70.93% over the 52-week high of Rs
2,649.
Recent Activity
- India's bleeding insurgencies: Lessons from Latin America
- Western Ghat report has imperialist mindset: Ecologist
- Lot more to India-China ties than border stand-off: Experts
- Major industrial conglomerates making a beeline for Haryana
- Man kidnapped 23 years ago finds kin thanks to Google Maps
- Bangalore's techies start 'brand tattoos' craze
- Indian circuses struggle to adapt after court bans
- Want hassle-free tatkal ticket? Personally visit special counters
- Rs 8K-crore plan for upgrading ICVs of Army
- Man arrested for attempt to attack TV host Ranjini Haridas
- The toxic truth about ripe mangoes
- Shift me from ‘Anda’ cell, pleads Sanjay Dutt
- Sreesanth, 2 other players 'confess'; more players under scanner
- Indefinite strike leaves city parched; mineral water bottles fly off shop shelves
- Jiju Janardhanan’s house in Kannur wears deserted look
- Tamil Brahmi script dating to 500 BC found near Erode
Post a Comment